These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 21953338
1. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ambrosi A, Salomonsson S, Eliasson H, Zeffer E, Skog A, Dzikaite V, Bergman G, Fernlund E, Tingström J, Theander E, Rydberg A, Skogh T, Öhman A, Lundström U, Mellander M, Winqvist O, Fored M, Ekbom A, Alfredsson L, Källberg H, Olsson T, Gadler F, Jonzon A, Kockum I, Sonesson SE, Wahren-Herlenius M. Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338 [Abstract] [Full Text] [Related]
2. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block. Tseng CE, Caldwell K, Feit S, Chan EK, Buyon JP. J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310 [Abstract] [Full Text] [Related]
5. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study. Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Cattaneo R, Tincani A, Motta M, Doria A, Zulian F, Milanesi O, Brucato A, Riboldi P, Meroni PL. Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486 [Abstract] [Full Text] [Related]
6. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies. Chang YL, Hsieh PC, Chang SD, Chao AS, Liang CC, Soong YK. Eur J Obstet Gynecol Reprod Biol; 2005 Oct 01; 122(2):167-71. PubMed ID: 16219517 [Abstract] [Full Text] [Related]
7. Long-term outcome of mothers of children with complete congenital heart block. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Am J Med; 1996 Mar 01; 100(3):328-32. PubMed ID: 8629679 [Abstract] [Full Text] [Related]
9. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. J Am Coll Cardiol; 2010 Jun 15; 55(24):2778-84. PubMed ID: 20538173 [Abstract] [Full Text] [Related]
11. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study. Martínez-Sánchez N, Pérez-Pinto S, Robles-Marhuenda Á, Arnalich-Fernández F, Martín Cameán M, Hueso Zalvide E, Bartha JL. Immunol Res; 2017 Apr 15; 65(2):487-494. PubMed ID: 28138914 [Abstract] [Full Text] [Related]
12. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study. Julkunen H, Miettinen A, Walle TK, Chan EK, Eronen M. J Rheumatol; 2004 Jan 15; 31(1):183-9. PubMed ID: 14705240 [Abstract] [Full Text] [Related]
13. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK. Arthritis Rheum; 2005 Oct 15; 52(10):3079-86. PubMed ID: 16200587 [Abstract] [Full Text] [Related]
15. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, Musset L, Wechsler B, Duhaut P, Piette JC. Arthritis Rheum; 2004 Oct 15; 50(10):3187-94. PubMed ID: 15476223 [Abstract] [Full Text] [Related]